Cue Biopharma, Inc. (CUE) has 12 identified peers for comparison in the Healthcare sector. Peers include ANIX, CGTX, COYA, DAWN, DRMA, ELYM and others.
CUE has a market capitalization of $34.53M, compared to an average peer market cap of $255.66M. CUE is notably smaller than its average peer.